Vycor Medical Statistics
Total Valuation
Vycor Medical has a market cap or net worth of 2.27 million. The enterprise value is 3.07 million.
| Market Cap | 2.27M |
| Enterprise Value | 3.07M |
Important Dates
The next estimated earnings date is Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vycor Medical has 33.37 million shares outstanding. The number of shares has increased by 0.35% in one year.
| Current Share Class | 33.37M |
| Shares Outstanding | 33.37M |
| Shares Change (YoY) | +0.35% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.15% |
| Owned by Institutions (%) | n/a |
| Float | 12.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.26 |
| PB Ratio | -0.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 37.96 |
| P/OCF Ratio | 36.97 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.97, with an EV/FCF ratio of 51.33.
| EV / Earnings | n/a |
| EV / Sales | 1.70 |
| EV / EBITDA | 15.97 |
| EV / EBIT | 63.63 |
| EV / FCF | 51.33 |
Financial Position
The company has a current ratio of 0.13
| Current Ratio | 0.13 |
| Quick Ratio | 0.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.99 |
| Debt / FCF | 16.02 |
| Interest Coverage | 0.46 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 3.56% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -1.17% |
| Weighted Average Cost of Capital (WACC) | 3.52% |
| Revenue Per Employee | 258,210 |
| Profits Per Employee | -54,900 |
| Employee Count | 7 |
| Asset Turnover | 2.14 |
| Inventory Turnover | 1.73 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.69% in the last 52 weeks. The beta is -0.52, so Vycor Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.52 |
| 52-Week Price Change | -47.69% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.10 |
| Relative Strength Index (RSI) | 46.83 |
| Average Volume (20 Days) | 19,644 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vycor Medical had revenue of 1.81 million and -384,300 in losses. Loss per share was -0.01.
| Revenue | 1.81M |
| Gross Profit | 1.51M |
| Operating Income | 48,219 |
| Pretax Income | -56,403 |
| Net Income | -384,300 |
| EBITDA | 110,312 |
| EBIT | 48,219 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 158,907 in cash and 957,725 in debt, with a net cash position of -798,818 or -0.02 per share.
| Cash & Cash Equivalents | 158,907 |
| Total Debt | 957,725 |
| Net Cash | -798,818 |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -4.25M |
| Book Value Per Share | -0.13 |
| Working Capital | -4.29M |
Cash Flow
In the last 12 months, operating cash flow was 61,384 and capital expenditures -1,606, giving a free cash flow of 59,778.
| Operating Cash Flow | 61,384 |
| Capital Expenditures | -1,606 |
| Depreciation & Amortization | 62,093 |
| Net Borrowing | -3,073 |
| Free Cash Flow | 59,778 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 83.37%, with operating and profit margins of 2.67% and -3.32%.
| Gross Margin | 83.37% |
| Operating Margin | 2.67% |
| Pretax Margin | -3.12% |
| Profit Margin | -3.32% |
| EBITDA Margin | 6.10% |
| EBIT Margin | 2.67% |
| FCF Margin | 3.31% |
Dividends & Yields
Vycor Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.35% |
| Shareholder Yield | -0.35% |
| Earnings Yield | -16.93% |
| FCF Yield | 2.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 15, 2013. It was a reverse split with a ratio of 0.0066666.
| Last Split Date | Jan 15, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.0066666 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |